If you work with third-party vendors, such as medical education or meeting planning companies, you have to heighten — not relax — your vigilance about compliance with the new regulations, said panelists at the National Pharma Congress...
MANY OF US are struggling with how to interpret the wave of new regulations around medical meetings. With an intense focus on conflict of interest, commercial support guidelines, and limits on gifts to physicians, a decidedly somber tone has taken...
As demonstrated at the September meeting of the National Task Force on CME Provider/Industry Collaboration, pharmaceutical companies are coming under almost microscopic scrutiny for their activities supporting accredited CME — not only from the...
DID YOU KNOW whistle-blowers who bring actions against pharmaceutical companies under the false claims act can be entitled to 25 to 30 percent of any settlement? Mary E. Riordan, senior counsel, Office of Inspector General, presented that...